RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Feature ArticlesFeature Articles

    The Brave new World of Social Media: Regulatory Perspective on Hashtags and Facebook Messenger

    This article discusses the emergence of social media for use in pharmaceutical advertising and promotion. The authors cover what “hashtags” mean, how they function, their uses and potential misuses and provide results of their investigation into how pharmaceutical companies using the social media platform “Facebook Messenger” respond to consumer questions received through social media. They conclude that the pharmaceutical industry and regulatory professionals should use s...
  • RAPS' LatestRAPS' Latest

    Walking the Digital Tight-Rope

    On behalf of the Regulatory Focus Board of Editors, we would like to introduce you to a collection of articles on the regulatory oversight of advertising, labeling and social media. Most likely, you are currently reading this on your iPad, smart phone or computer screen as are the majority of people seeking information in this digital-age. To align with current user-practices, Regulatory Focus magazine moved to a completely digital format in 2012. Along the same vein,...
  • Feature ArticlesFeature Articles

    Correlation Between OPDP Untitled or Warning Letters and OIG Settlements or Corporate Integrity Agreements with Sponsors

    This article discusses the existence of a correlation between OPDP enforcement letters and OIG settlements or corporate integrity agreements with pharmaceutical companies. Pharmaceutical companies promote their prescription drug products for a number of reasons, including to increase consumer awareness and the number of physicians prescribing the drugs and ultimately, to drive sales. Since these prescription products may carry serious risks, their promotion is r...
  • Feature ArticlesFeature Articles

    A (Technologically Stunted) Ad/Promo Reviewer Looks at Techy Solutions to Regulatory Issues

    I thought I was technologically savvy; at any given moment, I was juggling an iPhone, laptop, Blackberry, Kindle, iPad and who knows what other piece of technology I didn't actually need. Then, to my surprise, I encountered other "popular" forms of technology of which I was completely unaware. For instance, when interviewing potential candidates at a recent conference, I was handed business cards printed on the back with little boxes containing Rorschach-like images. Afte...